Upgrade to SI Premium - Free Trial

FDA MQSA Statistics A Modest Positive For Hologic (HOLX) - Needham

July 3, 2018 7:47 AM
Needham & Company analyst, Mike Matson, reiterated his Buy rating on shares of Hologic (NASDAQ: HOLX) after the FDA's latest ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments